SAMANTHA O'NEIL: Open Payments
NPI 1013745751 · SAINT MARYS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 38 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $203 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $143 |
| Novo Nordisk Inc | 6 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| ABBVIE INC. | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| Exact Sciences Corporation | 3 | $58 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Dexcom, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $16 |
Products named: Ozempic, EVENITY, KEVEYIS, Cologuard Collection Kit, UBRELVY, OTEZLA, FARXIGA, BREZTRI.
Industry payments across PA — which companies pay providers there.
